Ultra-sensitive biosensor could assist early cancer detection
Researchers claim to have developed an ultra-sensitive biosensor that could open up new opportunities for early detection of cancer and personalised medicine tailored to individual patients.

The device, which could be several hundred times more sensitive than other biosensors, combines the attributes of two distinctly different types of sensors, said Muhammad A Alam, a Purdue University professor of electrical and computer engineering.
‘Individually, both of these types of biosensors have limited sensitivity, but when you combine the two you get something that is better than either,’ said Alam in a statement.
The device — dubbed a Flexure-FET biosensor — is said to combine a mechanical sensor, which identifies a biomolecule based on its mass or size, with an electrical sensor that identifies molecules based on their electrical charge. The new sensor detects charged and uncharged biomolecules, allowing a broader range of applications than either type of sensor alone.
The sensor has two potential applications: personalised medicine, in which an inventory of proteins and DNA is recorded for individual patients to make more precise diagnostics and treatment decisions; and the early detection of cancer and other diseases.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
I´m sure politicians will be thumping tables and demanding answers - while Professor Bell, as reported above, says ´wait for detailed professional...